Federico Grossi - Aug 1, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Aug 1, 2022
Transactions value $
-$139,975
Form type
4
Date filed
8/2/2022, 04:18 PM
Previous filing
Jun 2, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$140K -2.5K -2.28% $55.99 107K Aug 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10b5-1 trading plan.
F2 Includes 323 shares from 4/30/2022 ESPP purchase.